Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2750308
Reference Type
Journal Article
Title
Interaction of lamotrigine with sodium valproate
Author(s)
Pisani, F; Di Perri, R; Perucca, E; Richens, A
Year
1993
Is Peer Reviewed?
1
Journal
The Lancet
ISSN:
0140-6736
EISSN:
1474-547X
Report Number
IPA/94/1042217
Volume
VOL 341 ISS May 8 1993
Issue
REF 5
Language
English
Abstract
IPA COPYRIGHT: ASHP Beneficial effects of combining 200-500 mg/day lamotrigine with 400-800 mg/day valproate sodium were studied in 7 patients (ages 20-63 yr) with frequent complex partial seizures who had been unsuccessfully treated with other anticonvulsants, including lamotrigine or valproate alone or combined with other drugs. In all cases, addition of valproate caused a striking increase in serum lamotrigine levels, which at times resulted in toxic symptoms that disappeared after reducing the dose of lamotrigine. After optimum therapy was established, serum lamotrigine levels ranged from 6 to 21 mcg/ml, compared with 2-6 mcg/ml in the absence of valproate.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity